Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Stockholders Equity of $305.79 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed an increase of +110.2% in Stockholders Equity from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$642.7 thousand | Q2 2013: -$1.23 million | Q3 2013: -$1.57 million | Q1 2014: -$1.66 million | Q2 2014: -$3.08 million | Q3 2014: -$4.47 million | Q1 2015: $7.32 million | Q2 2015: $4.56 million | Q3 2015: $1.93 million | Q1 2016: -$1.08 million | Q2 2016: -$5.12 million | Q3 2016: $49.1 thousand | Q1 2017: -$7.19 million | Q2 2017: -$6.59 million | Q3 2017: -$4.27 million | Q1 2018: $10.53 million | Q2 2018: $9.63 million | Q3 2018: $6.98 million | Q1 2019: $3.74 million | Q2 2019: $2.36 million | Q3 2019: $3.57 million | Q1 2020: $9.59 million | Q2 2020: $31.65 million | Q3 2020: $30.41 million | Q1 2021: $36.38 million | Q2 2021: $33.38 million | Q3 2021: $36.74 million | Q1 2022: $24.64 million | Q2 2022: $18.73 million | Q3 2022: $15.43 million | Q1 2023: $6.21 million | Q2 2023: $2.73 million | Q3 2023: -$1.79 million | Q1 2024: $18.43 million | Q2 2024: $11.50 million | Q3 2024: $68.26 million | Q1 2025: $127.65 million | Q2 2025: $104.98 million | Q3 2025: $83.87 million.
- Over the full 18 years of available data (2008 to 2025), CAPRICOR THERAPEUTICS, INC.'s Stockholders Equity has grown by 5,891.7%.
- Historical annual values: Fiscal year 2025: $305.79 million | Fiscal year 2024: $145.46 million | Fiscal year 2023: $22.60 million | Fiscal year 2022: $11.79 million | Fiscal year 2021: $31.37 million | Fiscal year 2020: $28.20 million | Fiscal year 2019: $6.84 million | Fiscal year 2018: $4.62 million | Fiscal year 2017: $11.23 million | Fiscal year 2016: -$4.00 million | Fiscal year 2015: -$1.03 million | Fiscal year 2014: -$6.25 million | Fiscal year 2013: -$534.9 thousand | Fiscal year 2012: $4.89 million | Fiscal year 2011: $1.66 million | Fiscal year 2010: $1.79 million | Fiscal year 2009: $911.8 thousand | Fiscal year 2008: $5.10 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: